Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What is laughable?
Let’s pretend we get 45% PASI 75 at 12 weeks. Otezla was 23% at 12 weeks and 33% at 16 weeks.
What is Prurisol then valued at? In your opinion. Otezla is over a billion in revs on its way to 2 billion a year.
I do not expect BILLIONS tomorrow or next year or the year after. When I say ipix has the potential for 7-8-9-10 etc Billion, that is several years down the line when\if Bom is taking in 1 billion a year, when if Prurisol delivers 40% pasi 75 for oral and trumps Otezla in 5 years making 2-3 billion a year etc.... just to clarify my position when I say ipix is worth billions.
Psoriasis - Crohns UP UC (IBD) -Cancer, Dermatology Eczema Acne and a new class of antibiotic. That is a very valuable lineup of indications. Imo
Six digit close?
Short interest is up a couple 100K over past months. BTD, 30% PASI 75 and a 40 - 80 million upfront deal for OM will get this back on track. IMO.
.40 stock will go to $7 plus imo on covering and new eyes w big money.
The above milestones are nothing to joke about if achieved.
.39625 share price. I’ll miss this crap one day
I believe with each day that passes we are closer to finding out the results. That is what I believe. I also believe there is a chance to be stellar results....and yes there is a chance for mediocre. But based on phase 2a and based on preclinical I believe strongly the 300-400 mg will be unbelievable. I also believe the results were so good it took the cro much longer to double check and deliver data. There will be no screw ups with this data is the idea imo.
I do not agree. I am not sure how one could come to that conclusion. Please explain.
There is still a chance these results are knock out good. Sometimes you forget based on what is said here
I dont think that is what I was looking for. I think PP or SCL posted it a while back. There was a secondary outcome for Otezla at 12 weeks in a trial and the data was poor.
Prurisol will prove to act quicker and safer imo.
No more of a general Derma comment. Like acne, HS, eczema etc....all indications that IPIX is trying to provide patients with better drugs than what is current.
I believe we hit the 33% at 12 weeks. I believe patients would scream for an oral that is 1000x safer and works 4 weeks quicker. All in one of the hottest sectors in Pharm right now.
Everyone cares about appearance these days.
Remember Otezla 12 week pasi rate? I think it was in the low 20%’s. If you have that data please post it
BTD and then Deal. No other way around it. It adds to much value. Unless, a milestone is added but I have a feeling the wait is welcomed as they prepare P data. Great P data adds 1000x more leverage
I believe the only “shady” thing Aspire can do is sell as many shares as they already have and take the price down to probably .38ish to gain the best and lowest 5 day average prior to news so they are then granted more shares on news day and milestone day. The only risk they face by this is that the public market does not take the stock over .50 on news day because then they would not get those milestone shares in return for cash. Jmo.
Yes look again. It’s in there.
Bahahaaaa. Watch and learn. Ipix is setting up for that watershed moment. If Prurisol rips a 33% PASI 75. With a 505 designation....what would you value ipix? I would say billions. That is not pumping. Ipix has an Arsenal .... period.
I would take a 12 billion buyout for everything though. That would be a steal though. Because if P alone beats up Otezla, we could sell P for that alone in about 3 years. Imo
I’d like them in order and only a couple days apart each. BTD, this will be the lowest milestone. 1 million.
This will allow ipix to finalize the OM deal if they get it IMO. While they are waiting for ink to dry release Prurisol results. 40% Pasi 75 IMO. Another 2 million milestone and the market wakes up to a SAFER ORAL drug than Otezla and more effective. 2 billion a year possibility imo. And then....drop the hammer! 50-100 million upfront for OM. First deal in ipix history.
I’d say - if above happens we are well over 7 dollars. On nasdaq
You will have a very long recap of what transpired once the deal is done and the 8-K is posted. I bet we see years of meetings and several companies involved.
The 5 day average will put Aspire in a great place for next weeks milestone news. IMO. That is why we sit at .38
Get ready . This will go over .50 on news day. I bet my shares on it. Aspire wants cheapest average yet wants to get shares so the .50 will hit.
Good news. It was actually 7875 - can’t forget about those 25 additional shares. It was a typo as my man Pete advised.
Do use proxy servers?
He’s not asking someone else. If you catch my drift.
Best wishes
Looooose! Ha. Actually I take 32%
Picked up 7850 more shares! Thank you. Let the Prurisol 52% PASI 75 results lose!!!!
Agree. I want the entire cow. If P is good, we are gonna fly. If we close the bom deal we really fly. Only weeks away is the hope
The amount of shares I owned in 2012 at 95 million OS has increased by 13x and 14x by end of week. So the current OS and possible OS after milestone will have only doubled.
I feel like I’m doing very well. Especially at these .40 range.
B-absssi ready for phase 3
Prurisol. Potentially ready for phase 3
B-OM Potentially ready for phase 3 - just need to get confirmation on BTD
IBD and K are cherries on top plus the many other deems in future.
Hmmm. It’s been easy work for me and many I know. Keep adding and dont worry about the in between for 10 years. I’ve been here adding for 6 on to 7 years in 2019. Have not sold a share. So it’s easy for me. I’ll cash out a couple thousand shares at a specific price and let the rest roll for the next 3 years and maybe longer depending.
If I were others that seem disturbed, I would have cut the cord and looked for the next diamond, but I am very happy with the progress.
Can you provide the data?
Agree. The fund and naysayers have this for now. BUT HOW QUICKLY THINGS CAN CHANGE! I’m ready and fully stocked
I read that as .38 right below ur highlighted section. Either way....if I were Aspire, I’d be playing dirty and keeping this as close to .38 as possible and let retail take it below.
We all know that any one of the announcements/milestones will take the share price well above .50
That’s why I’m hoping for BTD first since it’s less milestone cash for shares. But who knows. Anything can happen at any time. That’s why I accumulate and never sell. The day is always a day closer tomorrow.
We will not see heavy volume on the downside here. Aspire received shares at .38. They will not sell and by the 45K volume....I think I’m right. Lol
If I were Aspire, I would have dumped heavier volume like what happened last week to bring down avg share price because we are getting closer to D Day. When that day hits I’d suspect they want as many shares as possible
I believe it was applied for after the July 17th PR. Jmo. We will find out with in next 60 days
BTD pads the deal with many more millions. We see BTD first. That is what we wait for.
That slide 8. Unreal! Less than 5% of patients currently prescribed any OM treatment. USA - 450,000 patients annually. This market for OM and WORLd is unreal. If this is approved...I think every patient will be prescribed BOM. Hopefully WIRKDWIDE!
Hey. I’m invested and support my HOPES, MAYS,and whatever else I think. Can’t say the same for many others that are on this board. Those with multiple aliases. You know....
I fully EXPECT a huge PASI score from Prurisol. BUYING $2500 more tomorrow.
Huge market potential. Just imagine. If P is better than we think we have 2 blockbusters entering phase 3 and an antibiotic that is equal to a blockbuster.
In addition to representing a faster, less expensive path to market, products approved under the 505(b)(2) pathway can also sometimes qualify for several types of market exclusivity such as orphan drug exclusivity (seven years), new chemical entity exclusivity (five years), “other” exclusivity (three years for a “change” if certain criteria are met), and pediatric exclusivity (six months added to existing patents/exclusivity).
Let’s hope for 7 additional years!
Benefits of 505(b)(2)
505(b)(2) is particularly valuable for pharmaceutical and generics companies looking to alleviate competitive forces in their environments while still wanting to benefit from a development process that eliminates most nonclinical studies as well as extensive safety and efficacy tests.
Relatively low risk because of previous drug approval
Lower cost, accelerated development due to fewer studies
May qualify for three, five or seven years of market exclusivity............
Upped it by 5 Billion. Not sure if anyone caught the new expectation. I’m with you on a very positive outlook, but a billion dollars is not just a couple bucks my friend. To add 5 to your already 10 is a little steep imo. If we get 50%+ PASI 75 I think Prurisol could become a 3 - 4 billion a year drug by year 3-4 on market which then paved way for that type of buyout for Prurisol. But we need to add Psor Arthritis and others to the arsenal.
Jmo.